Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia.

MLA

Chan, Onyee, et al. “Side-Effects Profile and Outcomes of Ponatinib in the Treatment of Chronic Myeloid Leukemia.” Blood Advances, vol. 4, no. 3, Feb. 2020, pp. 530–38. EBSCOhost, https://doi.org/10.1182/bloodadvances.2019000268.

APA

Chan, O., Talati, C., Isenalumhe, L., Shams, S., Nodzon, L., Fradley, M., Sweet, K., & Pinilla-Ibarz, J. (2020). Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia. Blood Advances, 4(3), 530–538. https://doi.org/10.1182/bloodadvances.2019000268

Chicago

Chan, Onyee, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael Fradley, Kendra Sweet, and Javier Pinilla-Ibarz. 2020. “Side-Effects Profile and Outcomes of Ponatinib in the Treatment of Chronic Myeloid Leukemia.” Blood Advances 4 (3): 530–38. doi:10.1182/bloodadvances.2019000268.